Douglas Carr, SVP Finance & Operations at Century Therapeutics, Inc. (IPSC), sold 351 shares at $0.78 ($274) on 2025-02-03, disclosed to the SEC on 2025-02-05.
Open-market sale of $274 IPSC by SVP Finance & Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| IPSC | SELL | 2026-06-15 | $4K | — | Filing → |
| IPSC | SELL | 2026-06-09 | $526 | — | Filing → |
| IPSC | SELL | 2026-05-06 | $618 | — | Filing → |